Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo (Q38747333)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 March 2017

Language	Label	Description	Also known as
English	Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo	scientific article published on 10 March 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Yanjing Song

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Chuan Tong

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Yao Wang

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Yunhe Gao

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Hanren Dai

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Yelei Guo

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Xudong Zhao

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Yi Wang

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Zizheng Wang

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Weidong Han

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

10 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

867-878

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

copyright license

Creative Commons Attribution 4.0 International

10 March 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Gastric cancer stem cells: evidence, potential markers, and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Cancer statistics in China, 2015.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Driving CAR T-cells forward

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Human T lymphocyte genetic modification with naked DNA.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

HER2 and breast cancer stem cells: more than meets the eye.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Evolution of the cancer stem cell model

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Construction and evaluation of a novel humanized HER2-specific chimeric receptor

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Identification of gastric cancer stem cells using the cell surface marker CD44.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: a review

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

HER2 testing in gastric and gastroesophageal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

1 reference

https://api.crossref.org/works/10.1007%2FS13238-017-0384-8

21 January 2018

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6160382

4 November 2018

Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6160382

4 November 2018

CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/28284008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/28284008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13238-017-0384-8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28284008%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38747333&oldid=2202034646"